Paul Daruwala Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Paul Daruwala.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Paul Daruwala. Paul Daruwala is Chief Commercial Officer in Cidara Therapeutics, Inc. ($CDTX) and Chief Operating Officer in Cidara Therapeutics, Inc. ($CDTX).
Latest Insider Trading Transactions of Paul Daruwala
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 19 2021 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Operating Off ... | Option Exercise | A | 2.55 | 120,000 | 306,000 | 120,000 | |
| Mar 19 2021 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Operating Off ... | Option Exercise | A | 2.55 | 120,000 | 306,000 | 120,000 | |
| Mar 23 2020 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Operating Off ... | Option Exercise | A | 1.98 | 90,000 | 178,200 | 90,000 | |
| Jan 06 2020 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Operating Off ... | Sell | S | 3.42 | 2,340 | 8,003 | 53,532 | 55.9 K to 53.5 K (-4.19 %) |
| Dec 20 2019 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Operating Off ... | Option Exercise | A | 2.45 | 4,074 | 9,981 | 4,074 | |
| Dec 20 2019 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Operating Off ... | Option Exercise | A | 2.45 | 32,592 | 79,850 | 32,592 | |
| Dec 20 2019 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Operating Off ... | Option Exercise | D | 7.80 | 55,000 | 429,000 | 0 | |
| Dec 20 2019 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Operating Off ... | Option Exercise | A | 2.45 | 33,333 | 81,666 | 33,333 | |
| Dec 20 2019 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Operating Off ... | Option Exercise | D | 9.89 | 50,000 | 494,500 | 0 | |
| Dec 20 2019 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Operating Off ... | Option Exercise | A | 2.45 | 17,125 | 41,956 | 17,125 | |
| Dec 20 2019 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Operating Off ... | Option Exercise | D | 6.86 | 25,688 | 176,220 | 0 | |
| Oct 03 2019 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Operating Off ... | Sell | S | 1.88 | 3,295 | 6,195 | 55,872 | 59.2 K to 55.9 K (-5.57 %) |
| Sep 16 2019 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Operating Off ... | Option Exercise | M | 0.00 | 2,100 | 0 | 11,900 | |
| Sep 16 2019 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Operating Off ... | Option Exercise | M | 0.00 | 7,500 | 0 | 17,500 | |
| Sep 16 2019 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Operating Off ... | Grant | A | 0.00 | 2,100 | 0 | 59,167 | 57.1 K to 59.2 K (+3.68 %) |
| Sep 16 2019 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Operating Off ... | Grant | A | 0.00 | 7,500 | 0 | 57,067 | 49.6 K to 57.1 K (+15.13 %) |
| Mar 22 2019 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Operating Off ... | Option Exercise | A | 2.61 | 77,000 | 200,970 | 77,000 | |
| Mar 22 2019 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Operating Off ... | Option Exercise | A | 2.61 | 77,000 | 200,970 | 77,000 | |
| Mar 08 2019 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Operating Off ... | Sell | S | 2.55 | 2,240 | 5,714 | 49,567 | 51.8 K to 49.6 K (-4.32 %) |
| Feb 01 2019 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Operating Off ... | Option Exercise | M | 0.00 | 14,000 | 0 | 14,000 | |
| Feb 01 2019 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Operating Off ... | Grant | A | 0.00 | 6,000 | 0 | 51,807 | 45.8 K to 51.8 K (+13.10 %) |
| Apr 02 2018 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Operating Off ... | Option Exercise | A | 4.00 | 72,000 | 288,000 | 72,000 | |
| Apr 02 2018 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Operating Off ... | Option Exercise | A | 4.00 | 72,000 | 288,000 | 72,000 | |
| Sep 19 2017 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Commercial Of ... | Option Exercise | M | 0.00 | 25,000 | 0 | 25,000 | |
| Sep 19 2017 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Commercial Of ... | Grant | A | 0.00 | 15,000 | 0 | 45,807 | 30.8 K to 45.8 K (+48.69 %) |
| Apr 04 2017 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Commercial Of ... | Option Exercise | A | 7.80 | 55,000 | 429,000 | 55,000 | |
| Mar 18 2016 | CDTX | Cidara Therapeutic ... | Daruwala Paul | Chief Commercial Of ... | Option Exercise | A | 9.89 | 50,000 | 494,500 | 50,000 |
Page: 1